(2014). Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationCorrection: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients Following Treatment with 20 Mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India. Public Library of Science (PLoS), 2014.
MLA (9th ed.) CitationCorrection: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients Following Treatment with 20 Mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India. Public Library of Science (PLoS), 2014.
Warning: These citations may not always be 100% accurate.